Inventor
GU JIANXIN
US35 patents
⚠️ This page may combine multiple inventors who share the name “GU JIANXIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
20 patentsUS9517274B2Dec 13, 2016
Glycoconjugation processes and compositions
PFIZER34 citations97
US10583187B2Mar 10, 2020
Glycoconjugation processes and compositions
PFIZER17 citations94
US9950054B2Apr 24, 2018
Glycoconjugation processes and compositions
PFIZER24 citations94
US10226525B2Mar 12, 2019
Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
PFIZER18 citations93
US9492559B2Nov 15, 2016
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
PFIZER46 citations93
US10668164B2Jun 2, 2020
Immunogenic glycoprotein conjugates
PFIZER12 citations86
US11110160B2Sep 7, 2021
Glycoconjugation processes and compositions
PFIZER6 citations84
US10918708B2Feb 16, 2021
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
PFIZER4 citations84
US10105431B2Oct 23, 2018
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
PFIZER11 citations84
US11160855B2Nov 2, 2021
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
PFIZER7 citations83
US11090375B2Aug 17, 2021
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
PFIZER7 citations83
US10946086B2Mar 16, 2021
Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
PFIZER5 citations83
US11723965B2Aug 15, 2023
Glycoconjugation processes and compositions
PFIZER2 citations73
US11426456B2Aug 30, 2022
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
PFIZER1 citations73
US11872274B2Jan 16, 2024
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
PFIZER1 citations72
US11260119B2Mar 1, 2022
Escherichia coli compositions and methods thereof
PFIZER3 citations70
US12447203B2Oct 21, 2025
Glycoconjugation processes and compositions
PFIZER0 citations62
US12343389B2Jul 1, 2025
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
PFIZER0 citations62
US11707529B2Jul 25, 2023
Immunogenic glycoprotein conjugates
PFIZER0 citations62
US12128095B2Oct 29, 2024
Escherichia coli compositions and methods thereof
PFIZER0 citations59
WYETH CORP
8 patentsUS7445916B2Nov 4, 2008
Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
WYETH CORP22 citations92
US7268144B2Sep 11, 2007
Regiospecific synthesis of rapamycin 42-ester derivatives
WYETH CORP23 citations92
US7202256B2Apr 10, 2007
Proline CCI-779, production of and uses therefor, and two-step enzymatic synthesis of proline CCI-779 and CCI-779
WYETH CORP15 citations84
US7538119B2May 26, 2009
41-Methoxy isotope labeled rapamycin 42-ester
WYETH CORP12 citations82
US7605257B2Oct 20, 2009
Processes for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants
WYETH CORP7 citations73
US7625726B2Dec 1, 2009
Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
WYETH CORP2 citations63
US6995001B2Feb 7, 2006
Processing for preparing monoprotected diols from symmetric diols
WYETH CORP6 citations63
US7666901B2Feb 23, 2010
Analogs of 17-hydroxywortmannin as PI3K inhibitors
WYETH CORP2 citations50